|
| Status |
Public on Apr 13, 2022 |
| Title |
ALKBH5 promotes tumor progression by decreasing RIG-I expression mediated by N6-methyladenosine-dependent HNRNPC binding in HNSCC |
| Organism |
Homo sapiens |
| Experiment type |
Expression profiling by high throughput sequencing
Methylation profiling by high throughput sequencing
|
| Summary |
This SuperSeries is composed of the SubSeries listed below.
|
| |
|
| Overall design |
Refer to individual Series
|
| |
|
| Citation(s) |
35395767 |
| |
| Submission date |
Oct 13, 2021 |
| Last update date |
Apr 13, 2022 |
| Contact name |
Hailong Ma |
| E-mail(s) |
mahl21@sjtu.edu.cn
|
| Organization name |
Shanghai Ninth People’s Hospital, College of Stomatology, Shanghai Jiao Tong University School of Medicine
|
| Street address |
Zhizaoju Rd
|
| City |
Shanghai |
| ZIP/Postal code |
200011 |
| Country |
China |
| |
|
| Platforms (1) |
| GPL20301 |
Illumina HiSeq 4000 (Homo sapiens) |
|
| Samples (12)
|
|
| This SuperSeries is composed of the following SubSeries: |
| GSE185885 |
ALKBH5 promotes tumor progression by decreasing RIG-I expression mediated by N6-methyladenosine-dependent HNRNPC binding in HNSCC [MeRIP-seq] |
| GSE185886 |
ALKBH5 promotes tumor progression by decreasing RIG-I expression mediated by N6-methyladenosine-dependent HNRNPC binding in HNSCC [RNA-seq] |
|
| Relations |
| BioProject |
PRJNA771102 |
Less...
More...